NCT03967223 2026-02-25IGNYTE-ESOUSWM, LLC (dba US WorldMeds)Phase 2 Active not recruiting103 enrolled
NCT05492682 2025-09-05START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Active not recruiting15 enrolled